Sky-high sales prospects for Bristol Myers Squibb's new schizophrenia treatment Cobenfy may have to be scaled down after a trial designed to expand the label of the recently approved drug failed.

Gold is up 51% year to date and reached a record-high $4,059/oz on Oct. 8, silver is doing even better at a YTD increase of 70%, palladium is up 59%, and platinum has gained 76%. Copper is up 24%, ...